Prognostic role of hormone receptors in endometrial cancer: a systematic review and meta-analysis
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic role of hormone receptors in endometrial cancer: a systematic review and meta-analysis
Authors
Keywords
Endometrial cancer, Estrogen receptor, Progesterone receptor, Human epidermal growth factor receptor 2, Prognosis
Journal
World Journal of Surgical Oncology
Volume 13, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-06-24
DOI
10.1186/s12957-015-0619-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2014
- (2014) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A Bispecific HER2-Targeting FynomAb with Superior Antitumor Activity and Novel Mode of Action
- (2014) S. Brack et al. MOLECULAR CANCER THERAPEUTICS
- Immunosuppressive Glycodelin A is an independent marker for poor prognosis in endometrial cancer
- (2013) Miriam Lenhard et al. BMC CANCER
- Lack of Estrogen Receptor- Is Associated with Epithelial-Mesenchymal Transition and PI3K Alterations in Endometrial Carcinoma
- (2013) E. Wik et al. CLINICAL CANCER RESEARCH
- Retrospective analysis of prognostic variables and clinical outcomes in surgically staged intermediate risk endometrial carcinoma
- (2013) Gong-yi Zhang et al. European Journal of Obstetrics & Gynecology and Reproductive Biology
- Expression of ER-a36, a Novel Variant of Estrogen Receptor in Endometrial Carcinoma and Its Clinical Significance
- (2013) Lifang Sun et al. GYNECOLOGIC AND OBSTETRIC INVESTIGATION
- Trefoil factor family 3 (TFF3) expression and its interaction with estrogen receptor (ER) in endometrial adenocarcinoma
- (2013) Paulette Mhawech-Fauceglia et al. GYNECOLOGIC ONCOLOGY
- Progesterone receptor negativity is an independent risk factor for relapse in patients with early stage endometrioid endometrial adenocarcinoma
- (2013) Jutta Huvila et al. GYNECOLOGIC ONCOLOGY
- Expression of Estrogen Receptor-α as a Prognostic Factor in Patients With Uterine Serous Carcinoma
- (2013) Tomoko Sho et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Loss of GPER identifies new targets for therapy among a subgroup of ERα-positive endometrial cancer patients with poor outcome
- (2012) C Krakstad et al. BRITISH JOURNAL OF CANCER
- Clinicopathological and prognostic impact of human epidermal growth factor receptor type 2 (HER2) and hormone receptor expression in uterine papillary serous carcinoma
- (2012) Shinichi Togami et al. CANCER SCIENCE
- The expression ratios of estrogen receptor α (ERα) to estrogen receptor β1 (ERβ1) and ERα to ERβ2 identify poor clinical outcome in endometrioid endometrial cancer
- (2012) Gian Franco Zannoni et al. HUMAN PATHOLOGY
- Prognostic Role of Hormone Receptors in Ovarian Cancer
- (2012) Dong Zhao et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Markers for individualised therapy in endometrial carcinoma
- (2012) Helga B Salvesen et al. LANCET ONCOLOGY
- DNA ploidy may be a prognostic marker in stage I and II serous adenocarcinoma of the endometrium
- (2012) Manohar Pradhan et al. VIRCHOWS ARCHIV
- An exploratory analysis of γ-synuclein expression in endometrioid endometrial cancer
- (2012) Jing Zou et al. BMJ Open
- Tetraspanin CD151 is a novel prognostic marker in poor outcome endometrial cancer
- (2011) M A Voss et al. BRITISH JOURNAL OF CANCER
- Clinical and biological impact of EphA2 overexpression and angiogenesis in endometrial cancer
- (2011) William M. Merritt et al. CANCER BIOLOGY & THERAPY
- Survival outcomes in endometrial cancer patients are associated with CXCL12 and estrogen receptor expression
- (2011) Ashley S. Felix et al. INTERNATIONAL JOURNAL OF CANCER
- Ploidy and S-phase fraction are correlated with lymphovascular space invasion that is predictive of outcomes in endometrial cancer
- (2011) Taejong Song et al. International Journal of Clinical Oncology
- Phase II Study of Temsirolimus in Women With Recurrent or Metastatic Endometrial Cancer: A Trial of the NCIC Clinical Trials Group
- (2011) Amit M. Oza et al. JOURNAL OF CLINICAL ONCOLOGY
- Sirtuin 1 (SIRT1) and steroid hormone receptor activity in cancer
- (2011) R L Moore et al. JOURNAL OF ENDOCRINOLOGY
- Progesterone: the ultimate endometrial tumor suppressor
- (2011) Shujie Yang et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Expression of HER-2 affects patient survival and paclitaxel sensitivity in endometrial cancer
- (2010) N Mori et al. BRITISH JOURNAL OF CANCER
- The relationship of cerb B 2 expression with estrogen receptor and progesterone receptor and prognostic parameters in endometrial carcinomas
- (2010) Aylin Gul et al. Diagnostic Pathology
- Phase II study of fulvestrant in recurrent/metastatic endometrial carcinoma: A Gynecologic Oncology Group Study
- (2010) Allan L. Covens et al. GYNECOLOGIC ONCOLOGY
- Aromatase, Cyclooxygenase 2, HER-2/neu, and P53 as Prognostic Factors in Endometrioid Endometrial Cancer
- (2010) Vincent H.W.M. Jongen et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- ErbB family receptor inhibitors as therapeutic agents in breast cancer: Current status and future clinical perspective
- (2010) Ruchi Saxena et al. MEDICINAL RESEARCH REVIEWS
- Comparative Performance of the 2009 International Federation of Gynecology and Obstetricsʼ Staging System for Uterine Corpus Cancer
- (2010) Sharyn N. Lewin et al. OBSTETRICS AND GYNECOLOGY
- Prognostic significance and clinical importance of estrogen receptor α and β in human endometrioid adenocarcinomas
- (2010) Mylonas ONCOLOGY REPORTS
- EphA2 overexpression is associated with lack of hormone receptor expression and poor outcome in endometrial cancer
- (2009) Aparna A. Kamat et al. CANCER
- HER-2/neu receptor gene status in endometrial carcinomas: a tissue microarray study
- (2009) Mina Xu et al. HISTOPATHOLOGY
- GATA3 expression in estrogen receptor α-negative endometrial carcinomas identifies aggressive tumors with high proliferation and poor patient survival
- (2008) Ingeborg B. Engelsen et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- HER2 gene amplification and EGFR expression in a large cohort of surgically staged patients with nonendometrioid (type II) endometrial cancer
- (2008) G E Konecny et al. BRITISH JOURNAL OF CANCER
- Expression of estrogen receptor-alpha and -beta and progesterone receptor-A and -B in a large cohort of patients with endometrioid endometrial cancer
- (2008) Vincent Jongen et al. GYNECOLOGIC ONCOLOGY
- HER-2/neuoverexpression and amplification in uterine serous papillary carcinoma: comparative analysis of immunohistochemistry, real-time reverse transcription-polymerase chain reaction, and fluorescencein situhybridization
- (2007) F.E ODICINO et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started